UnitedHealth Group (UNH)
NYSEHealth CareHealthcare PlansSnapshot 2026-07-07
$428.28+2.46%
Close 2026-07-07 · 1-day change
Reading UNH? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track UNH free→NYSEHealth CareHealthcare PlansSnapshot 2026-07-07
Reading UNH? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track UNH free→QuarterlyIQ Insights · UNH
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition. On April 21, 2026, UnitedHealth Group Incorporated (the “Company”) issued a press release announcing its first quarter 2026 results. A copy of the press release is furnished herewith as Exhibit 99.1. The press release also includes a hyperlink to a pdf document which is furnished herewith as Exhibit 99.2. Exhibits 99.1 and 99.2 are incorporated herein by reference. The information in this
Chief Accounting Officer — Dennis Stankiewicz: Dennis Stankiewicz was promoted to Chief Accounting Officer while continuing as Corporate Controller.
Stephen Hemsley: The filing details an amendment to a stock option, adding a share holding requirement.
Results of Operations and Financial Condition. On January 27, 2026, UnitedHealth Group Incorporated (the “Company”) issued a press release announcing its fourth quarter and full year 2025 results. A copy of the press release is furnished herewith as Exhibit 99.1. The press release also includes a hyperlink to a pdf document which is furnished herewith as Exhibit 99.2. Exhibits 99.1 and 99.2 are incorporated herein by reference. The information in this
Director — Scott Gottlieb, M.D.: Dr. Scott Gottlieb was appointed as an independent director of the Company.
shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.
shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing. Forward-Looking Statements The statements, estimates, projections, guidance or outlook contained in this report include “forward-looking” statements which are intended to take advan…
shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing. Forward-Looking Statements The statements, estimates, projections, guidance or outlook contained in this report include “forward-looking” statements which are intended to take advan…
Chief Financial Officer — Wayne S. DeVeydt: UnitedHealth Group hired a new Chief Financial Officer from an external position.
shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.
Chief Executive Officer — Andrew Witty: Mr. Witty retired and his performance-based restricted stock units were cancelled.
Director — Andrew Witty: Mr. Andrew Witty resigned as a director of the Company.
CEO — Andrew Witty: Andrew Witty stepped down as CEO and was succeeded by Steve Hemsley.
Executive Vice President, Governance, Compliance and Information Security — Heather Cianfrocco: Heather Cianfrocco was promoted to a new enterprise-wide role.
shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.
Results of Operations and Financial Condition. On January 16, 2025, UnitedHealth Group Incorporated (the “Company”) issued a press release announcing its fourth quarter and full year 2024 results. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference. The information in this
shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.
shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.
Executive Vice President, Chief Legal Officer and Corporate Secretary — Rupert Bondy: Rupert Bondy is transitioning to a new role within the company.
Mr. Rex: Compensation and equity arrangements for Mr. Rex were updated.
shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.
President, CFO — John Rex: John Rex has been appointed as President in addition to his existing role as CFO.
President and Chief Operating Officer — Dirk McMahon: Mr. Dirk McMahon, President and Chief Operating Officer, is retiring effective April 1, 2024.
Results of Operations and Financial Condition. On January 12, 2024, UnitedHealth Group Incorporated (the “Company”) issued a press release announcing its fourth quarter and full year 2023 results. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference. The information in this
Director — Charles D. Baker: Appointment of Charles D. Baker as an independent director and to serve on specific committees.
Importance-ranked changes since the prior daily snapshot.
Signal changed from 'mild_favorable' to 'mixed'.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.